Ruth E. Langley
About
Ruth E. Langley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Ruth E. Langley has authored 104 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 32 papers in Surgery. Recurrent topics in Ruth E. Langley's work include Gastric Cancer Management and Outcomes (32 papers), Esophageal Cancer Research and Treatment (24 papers) and Prostate Cancer Treatment and Research (16 papers). Ruth E. Langley is often cited by papers focused on Gastric Cancer Management and Outcomes (32 papers), Esophageal Cancer Research and Treatment (24 papers) and Prostate Cancer Treatment and Research (16 papers). Ruth E. Langley collaborates with scholars based in United Kingdom, Netherlands and United States. Ruth E. Langley's co-authors include William Allum, Sally Stenning, David Cunningham, Stephen Falk, Cornelis J.�H. van de Velde, M. Nicolson, F. Lofts, Simon Weeden, J.H. Scarffe and J N Thompson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
In The Last Decade
Ruth E. Langley
97 papers receiving 8.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ruth E. Langley United Kingdom | 30 | 6.5k | 4.2k | 2.8k | 1.9k | 910 | 104 | 9.0k | ||
| M. Nicolson United Kingdom | 38 | 7.9k 1.2× | 4.2k 1.0× | 4.5k 1.6× | 2.3k 1.2× | 1.3k 1.4× | 112 | 10.8k | ||
| H. Wilke Germany | 41 | 5.9k 0.9× | 3.7k 0.9× | 3.7k 1.3× | 1.3k 0.7× | 942 1.0× | 142 | 8.3k | ||
| William Allum United Kingdom | 37 | 9.4k 1.4× | 6.8k 1.6× | 3.2k 1.2× | 3.5k 1.8× | 977 1.1× | 140 | 12.2k | ||
| Stephen Falk United Kingdom | 38 | 7.7k 1.2× | 5.6k 1.3× | 4.9k 1.8× | 2.1k 1.1× | 840 0.9× | 123 | 11.4k | ||
| David B. Smith United Kingdom | 23 | 4.7k 0.7× | 3.1k 0.7× | 3.0k 1.1× | 1.6k 0.8× | 642 0.7× | 58 | 7.4k | ||
| Giuseppe Aprile Italy | 38 | 5.0k 0.8× | 2.5k 0.6× | 5.6k 2.0× | 1.3k 0.7× | 2.0k 2.2× | 232 | 9.8k | ||
| F. Lofts United Kingdom | 18 | 4.5k 0.7× | 3.1k 0.7× | 1.8k 0.7× | 1.6k 0.8× | 545 0.6× | 45 | 6.3k | ||
| Yelena Y. Janjigian United States | 48 | 5.0k 0.8× | 2.4k 0.6× | 5.0k 1.8× | 1.1k 0.6× | 1.9k 2.1× | 253 | 8.5k | ||
| Narikazu Boku Japan | 61 | 10.0k 1.5× | 6.3k 1.5× | 8.1k 2.9× | 3.1k 1.6× | 1.8k 2.0× | 541 | 15.3k | ||
| Timothy Iveson United Kingdom | 35 | 10.3k 1.6× | 8.4k 2.0× | 9.2k 3.3× | 2.7k 1.4× | 2.0k 2.2× | 117 | 17.1k |
Countries citing papers authored by Ruth E. Langley
Since
Specialization
Citations
This map shows the geographic impact of Ruth E. Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth E. Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth E. Langley more than expected).
Fields of papers citing papers by Ruth E. Langley
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ruth E. Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth E. Langley. The network helps show where Ruth E. Langley may publish in the future.
Co-authorship network of co-authors of Ruth E. Langley
This figure shows the co-authorship network connecting the top 25 collaborators of Ruth E. Langley. A scholar is included among the top collaborators of Ruth E. Langley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth E. Langley. Ruth E. Langley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Oza, Bhavna, Eleni Frangou, Tim Eisen, et al.. (2025). Determining the Impact of Histology on the Incidence, Pattern, and Timing of Recurrences in Patients with Renal Cell Carcinoma: A Pooled Analysis from the SORCE and ASSURE Trials. European Urology Open Science. 79. 19–26.
2.
James, Nicholas D., Hannah Rush, Matthew Nankivell, et al.. (2025). Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer—Randomised comparison from the STAMPEDE trial platform.. Journal of Clinical Oncology. 43(5_suppl). 21–21.
3.
Rush, Hannah, Alison Fielding, Lisa Pickering, et al.. (2024). Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition. British Journal of Cancer. 131(3). 515–523.
4.
Rosen, Stuart D., et al.. (2023). Cardiovascular health: an important component of cancer survivorship. SHILAP Revista de lepidopterología. 2(1). e000090–e000090.
5.
Grosser, Bianca, David Cunningham, Matthew Nankivell, et al.. (2023). Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British Journal of Cancer. 130(3). 457–466.
6.
Beuque, Manon, Derek Magee, Avishek Chatterjee, et al.. (2023). Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides. Journal of Pathology Informatics. 14. 100192–100192.
7.
Macnair, Archie, Matthew Nankivell, Macey L. Murray, et al.. (2023). Healthcare systems data in the context of clinical trials – A comparison of cardiovascular data from a clinical trial dataset with routinely collected data. Contemporary Clinical Trials. 128. 107162–107162.
8.
Saito, Yuichi, Takaki Yoshikawa, Takashi Oshima, et al.. (2021). Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma. British journal of surgery. 109(3). 291–297.
9.
Macnair, Archie, Sharon Love, Macey L. Murray, et al.. (2021). Accessing routinely collected health data to improve clinical trials: recent experience of access. Trials. 22(1). 340–340.
10.
Cattaneo, Marco, Lina Badimón, Giancarlo Agnelli, et al.. (2020). Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention. ecancermedicalscience. 14.
11.
Allum, William, Elizabeth Smyth, Jane Blazeby, et al.. (2019). Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction. British journal of surgery. 106(9). 1204–1215.
12.
Smyth, Elizabeth, Shenli Zhang, David Cunningham, et al.. (2017). Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy. Clinical Cancer Research. 23(24). 7543–7549.
13.
Cafferty, Fay, et al.. (2017). Co-enrolment of Participants into Multiple Cancer Trials: Benefits and Challenges. Clinical Oncology. 29(7). e126–e133.
14.
Mulvenna, P., Matthew Nankivell, Rachael Barton, et al.. (2016). Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. The Lancet. 388(10055). 2004–2014.
15.
Langley, Ruth E.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 297–297.
16.
Smyth, Elizabeth, Matteo Fassan, David Cunningham, et al.. (2016). Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Journal of Clinical Oncology. 34(23). 2721–2727.
17.
Langley, Ruth E. & Peter M. Rothwell. (2014). Aspirin in gastrointestinal oncology. Current Opinion in Oncology. 26(4). 441–447.
18.
Shah, Syed Imran Ali, et al.. (2014). Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer. PubMed. 10(1). 42–42.
19.
Smyth, Elizabeth, Ruth E. Langley, Sally Stenning, et al.. (2013). ST03: A randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with operable gastric, esophagogastric junction (OGJ), or lower esophageal adenocarcinoma.. Journal of Clinical Oncology. 31(15_suppl). TPS4156–TPS4156.
20.
Bump, Edward A., Susan J. Braunhut, Sanjeewani T. Palayoor, et al.. (1994). Novel concepts in modification of radiation sensitivity. International Journal of Radiation Oncology*Biology*Physics. 29(2). 249–253.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M. Nicolson Breakdown of academic impact, for papers by H. Wilke Breakdown of academic impact, for papers by William Allum Breakdown of academic impact, for papers by Stephen Falk Breakdown of academic impact, for papers by David B. Smith Breakdown of academic impact, for papers by Giuseppe Aprile Breakdown of academic impact, for papers by F. Lofts Breakdown of academic impact, for papers by Yelena Y. Janjigian Breakdown of academic impact, for papers by Narikazu Boku Breakdown of academic impact, for papers by Timothy Iveson